Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ceva-phylaxia veterinary biologicals co. ltd - live attenuated infectious bronchitis disease virus, massachusetts type, strain b48 - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Kanada - Kiingereza - Health Canada

abbvie corporation - ofloxacin - solution - 0.3% - ofloxacin 0.3% - antibacterials

Bahareni - Kiingereza - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - povidone - ear drops

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

genera inc - avian infectious brochitis virus massachusetts serotype strain h-120 - lyophilisate for suspension for oculonasal or spray app - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Uingereza - Kiingereza - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - infectious bronchitis virus, newcastle disease virus - lyophilisate for oculonasal suspension/use in drinking water - live viral vaccine - chickens

Israeli - Kiingereza - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - solution - zuclopenthixol as dihydrochloride 20 mg/ml - zuclopenthixol - zuclopenthixol - acute schizophrenia and other acute psychoses.

Marekani - Kiingereza - NLM (National Library of Medicine)

heel inc - spigelia anthelmia (unii: wyt05213ge) (spigelia anthelmia - unii:wyt05213ge) - spigelia anthelmia 6 [hp_x] in 300 mg

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

genera inc - newcastle disease virus, live - lyophilisate for oculonasal suspension/use in drinking water - . - newcastle disease virus / paramyxovirus - chickens - immunological - live vaccine

Israeli - Kiingereza - Ministry of Health

j-c health care ltd - haloperidol - solution (oral) - haloperidol 2 mg/ml - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.

Kanada - Kiingereza - Health Canada

searchlight pharma inc - periciazine - drops - 10mg - periciazine 10mg - phenothiazines